Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID 2022-08-09 00:00
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio 2022-08-08 20:00
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development 2022-08-08 12:24
BIO Asia-Taiwan 2022 concludes, marking another successful edition of the region's biggest bioindustry-focused conference and exhibition 2022-08-08 10:00
Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1 Small Molecule Inhibitor Prodrug ASC61 for Treatment of Advanced Solid Tumors 2022-08-08 08:10
Transcenta Announces the Appointment of Dr. Caroline Germa as Executive Vice President, Global Medicine Development and Chief Medical Officer 2022-08-08 08:00
Innovent Announces First Patient Dosed in Phase 1 Study of IBI324 (VEGF-A/Ang-2 Bispecific Antibody) in Patients with Diabetic Macular Edema 2022-08-08 08:00
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant 2022-08-08 07:55
BGI's Global Life Science Research Leadership Recognized in 2022 Nature Index 2022-08-05 22:18
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China 2022-08-04 23:30
MGI Announces Commercial Availability of HotMPS Sequencing Chemistry*and Instrument**in the United Kingdom 2022-08-04 22:50
Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector 2022-08-04 22:01
Firmenich Appoints Maurizio Clementi ad interim President of its Taste & Beyond Division 2022-08-03 20:57
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients 2022-08-03 16:50
Yidu Tech Releases FY2022 ESG Report, Using Socially Beneficial Technology to Drive the Sustainable Development of "Green Healthcare" 2022-08-03 15:09
Ogawa World Berhad Won the Asia Pacific Enterprise Awards 2022 Malaysia under Inspirational Brand Category 2022-08-03 13:14
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-08-03 08:30
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination 2022-08-02 22:49
Metabolon Awarded ISO 9001:2015 Recertification 2022-08-02 20:57
Sironax Announces Closing of $200 Million Series B Financing 2022-08-02 19:00
1 65 66 67 68 69 211